On November 11, Aehr Test rose 8.53% in Pre-Market Trading, trading at $59.57, with turnover of $163 million.
The move was linked to continued market focus on the company’s stronger-than-expected quarterly results, raised full-year revenue outlook, and ongoing progress in AI chip testing orders and deployments.
Previously disclosed results showed adjusted EPS of $0.28 versus expectations of $0.11, while revenue reached $33.007 million versus $27.072 million expected. The company also said backlog stood at $100.9 million as of September 25, highlighted deployment progress with a major AI accelerator customer, and had earlier received about $6 million in follow-on AI chip testing equipment orders for delivery over the following six months. These updates reinforced demand visibility for its FOX-XP and Sonoma platforms and remained the main trading catalyst behind the share move.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments